Jaguar Health (JAGX) EBT Margin (QoQ) (2015 - 2026)
Jaguar Health (JAGX) EBT Margin (QoQ) (2015 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - |
| 10 | Jaguar Health | 497,735.41 | -9.57 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75,997.00 |
| Dec 31, 2025 | -40,400.00 |
| Sep 30, 2025 | 4,154.00 |
| Jun 30, 2025 | 12,411.00 |
| Mar 31, 2025 | -18,694.00 |
| Dec 31, 2024 | 3,078.00 |
| Sep 30, 2024 | 3,141.00 |
| Jun 30, 2024 | 4,463.00 |
| Mar 31, 2024 | 627.00 |
| Dec 31, 2023 | -12,376.00 |
| Sep 30, 2023 | 18,689.00 |
| Jun 30, 2023 | 2.71 Mn |
| Mar 31, 2023 | -182,389.00 |
| Dec 31, 2022 | -2.53 Mn |
| Sep 30, 2022 | -8,099.00 |
| Jun 30, 2022 | 9.05 Mn |
| Mar 31, 2022 | -9.01 Mn |
| Dec 31, 2021 | 129,407.00 |
| Sep 30, 2021 | 173,286.00 |
| Jun 30, 2021 | -272,118.00 |